Skip to main content
Caplight Logo









Cleerly

Cleerly

Private
Denver, ColoradoHealthcare & Life Scienceshttps://cleerlyhealth.com/

Last Round

Series C

Extension

Dec 4, 2024

Total Funding Raised

$383M

Company Overview

Cleerly is a healthcare technology company that offers an AI-driven platform for quantifying and characterizing plaque buildup in coronary arteries to enhance the identification and treatment of at-risk patients.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Healthcare Analytics

Business Model

B2B2C

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

coronary computed tomography angiographyCCTAAI heart imagingplaque quantificationAI-QCTcardiovascular imagingclinical decision supportAI diagnosticscoronary artery diseasemedical imaging AIheart scan analysisusage-based billingradiology AIcardiology softwaredigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cleerly Comparables

Compare Cleerly with similar companies based on industry and business-model similarity.

Cleerly comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Elucid
88%
HeartFlow
82%
Artrya Ltd
81%

Cleerly Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series C ExtensionDec 4, 2024
Series CJul 25, 2022
Series BJun 21, 2021
Series AApr 3, 2020

Key People

Founding team and executive leadership

Parker Cassidy

Chief Operating Officer

Executive Team

Cleerly Investors

Notable investors and investment history

Cleerly investors
InvestorRounds
Breyer CapitalSeries C
DigiTx PartnersSeries B, Series C
New Leaf Venture PartnersSeries B, Series C
Heartland Healthcare CapitalSeries C
Catalytic Impact FoundationSeries C
Cigna VenturesSeries B, Series C
Fidelity Management & Research CompanySeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 14, 2026

    Accused of infringing on six patents related to AI diagnostic tools.

  • Mar 25, 2026

    Launched Cleerly PREVIEW for CAD imaging case prioritization.

Recent news

Latest coverage and updates

  • launchesJul 30, 2026

    Cleerly was planning to launch polygenic Risk Score Test for coronary artery disease on Jul 30th '26.

  • partners_withJul 30, 2026

    Cleerly partnered with Allelica on Jul 30th '26.

  • attends_eventJul 7, 2026

    Cleerly will attend event 21st Annual Scientific Meeting of the Society of Cardiovascular Computed Tomography on Jul 9th '26.

  • attends_eventJul 7, 2026

    Cleerly attended event SCCT2026 on Jul 7th '26.

Cleerly Filings

Explore SEC and related filing metadata, where available.

Cleerly filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cleerly's valuation, stock price, and market status.

Is Cleerly a public or private company?

Cleerly is a private company.

What is the current stock price of Cleerly?

Cleerly is a private company with no public stock price. No recent secondary market data is available.

How much is Cleerly worth (valuation)?

Valuation information for Cleerly is not publicly available.

Can I buy Cleerly stock?

Cleerly shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cleerly's last funding round?

Cleerly's most recent funding round was Series C Extension on December 4, 2024.

Who are the main investors in Cleerly?

Key investors in Cleerly include Fidelity Management & Research Company, Vensana Capital, T. Rowe Price, Insight Partners.

Will Cleerly IPO soon?

No public IPO plans have been announced for Cleerly.

How can I track Cleerly secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cleerly's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDenver, Colorado
Employee Range295
Year Founded2017
Last FundingDec 4, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?